IL135825A0 - Use of mirtazapine for treating sleep apneas - Google Patents

Use of mirtazapine for treating sleep apneas

Info

Publication number
IL135825A0
IL135825A0 IL13582598A IL13582598A IL135825A0 IL 135825 A0 IL135825 A0 IL 135825A0 IL 13582598 A IL13582598 A IL 13582598A IL 13582598 A IL13582598 A IL 13582598A IL 135825 A0 IL135825 A0 IL 135825A0
Authority
IL
Israel
Prior art keywords
mirtazapine
treating sleep
sleep apneas
apneas
treating
Prior art date
Application number
IL13582598A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL135825A0 publication Critical patent/IL135825A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13582598A 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas IL135825A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203548 1997-11-14
PCT/EP1998/007330 WO1999025356A1 (en) 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas

Publications (1)

Publication Number Publication Date
IL135825A0 true IL135825A0 (en) 2001-05-20

Family

ID=8228923

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13582598A IL135825A0 (en) 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas
IL135825A IL135825A (en) 1997-11-14 2000-04-25 Production of a medicinal product that includes myrtzepine for the treatment of sleep apnea

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL135825A IL135825A (en) 1997-11-14 2000-04-25 Production of a medicinal product that includes myrtzepine for the treatment of sleep apnea

Country Status (20)

Country Link
US (1) US6303595B1 (cs)
EP (1) EP1030667B1 (cs)
JP (1) JP2001522891A (cs)
KR (1) KR20010032009A (cs)
CN (1) CN1154495C (cs)
AT (1) ATE289816T1 (cs)
AU (1) AU737590B2 (cs)
BR (1) BR9815098A (cs)
CA (1) CA2309744A1 (cs)
CZ (1) CZ296282B6 (cs)
DE (1) DE69829202T2 (cs)
DK (1) DK1030667T3 (cs)
ES (1) ES2238781T3 (cs)
HU (1) HUP0100080A3 (cs)
IL (2) IL135825A0 (cs)
NO (1) NO20002218L (cs)
PL (1) PL192272B1 (cs)
PT (1) PT1030667E (cs)
TR (1) TR200001293T2 (cs)
WO (1) WO1999025356A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2321900C (en) 1998-02-27 2011-07-19 The Board Of Trustees Of The University Of Illinois Agents with serotonin-related activity for the treatment for sleep apnea
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
DE60117122T2 (de) * 2000-02-11 2006-07-27 Akzo Nobel N.V. Verwendung von mirtazapin zur behandlung von schlafstörungen
US20020183306A1 (en) * 2001-05-30 2002-12-05 Pfizer Inc. Combination treatment for sleep disorders including sleep apnea
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
ES2426915T3 (es) 2003-09-10 2013-10-25 Brentwood Equities Ltd. Diastereoisómeros de 4-ariloxi-3-hidroxipiperidinas
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
WO2006055854A2 (en) * 2004-11-17 2006-05-26 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtazapine treatment
CA2590802A1 (en) * 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
CA2684021A1 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of an enantiomer of a tetracyclic benzazepine
EP2167096A4 (en) * 2007-06-13 2010-07-14 Cypress Bioscience Inc IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM
WO2013188806A1 (en) 2012-06-14 2013-12-19 The Regents Of The University Of Michigan Sleep apnea treatment
CA3013771C (en) 2015-02-27 2024-01-02 Kindred Biosciences, Inc. Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
DE69636393T2 (de) * 1995-10-24 2006-12-07 Grünenthal GmbH Montirelin zur verhinderung der schlafapnoe
SE9504537D0 (sv) 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent

Also Published As

Publication number Publication date
JP2001522891A (ja) 2001-11-20
DE69829202T2 (de) 2005-07-21
HUP0100080A3 (en) 2002-05-28
HUP0100080A2 (hu) 2001-08-28
CA2309744A1 (en) 1999-05-27
NO20002218D0 (no) 2000-04-28
NO20002218L (no) 2000-05-12
DE69829202D1 (de) 2005-04-07
EP1030667A1 (en) 2000-08-30
EP1030667B1 (en) 2005-03-02
CN1154495C (zh) 2004-06-23
WO1999025356A1 (en) 1999-05-27
ES2238781T3 (es) 2005-09-01
KR20010032009A (ko) 2001-04-16
PL192272B1 (pl) 2006-09-29
AU1754899A (en) 1999-06-07
TR200001293T2 (tr) 2002-09-23
IL135825A (en) 2006-12-31
CN1278731A (zh) 2001-01-03
BR9815098A (pt) 2000-10-10
CZ296282B6 (cs) 2006-02-15
HK1029932A1 (en) 2001-04-20
ATE289816T1 (de) 2005-03-15
CZ20001751A3 (cs) 2000-10-11
DK1030667T3 (da) 2005-06-20
US6303595B1 (en) 2001-10-16
AU737590B2 (en) 2001-08-23
PL340467A1 (en) 2001-02-12
PT1030667E (pt) 2005-06-30

Similar Documents

Publication Publication Date Title
IL135825A0 (en) Use of mirtazapine for treating sleep apneas
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
NZ335981A (en) Ketobenzamides as calpain inhibitors
YU65502A (sh) Supstituisani beta-karbolini sa ikb-kinaza inhibirajućim dejstvom
AU3831301A (en) Method for treating ocular pain
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
DE69914357D1 (de) Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
ATE326209T1 (de) Verminderung des haarwuchses
ID28441A (id) Terapi untuk memperbaiki kesadaran
IL150125A0 (en) Novel compounds
MY133125A (en) Novel dihydroxyhexanoic acid derivatives
SI1546182T1 (sl) Sestavki in postopki za diagnozo in zdravljenje tumorja
GB0018951D0 (en) Novel compounds
AP2001002274A0 (en) Rescorcinol derivatives.
SE0004101D0 (sv) New use
MXPA05004133A (es) Nuevos compuestos antitumorales.
GB0027705D0 (en) Novel compounds
IL131478A0 (en) Methods for treatment of scar tissue
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
ZA9711468B (en) New use of comt inhibitors
MXPA04000418A (es) Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
DE60102481D1 (en) Purinriboside als antiarrhythmika
AP2000001907A0 (en) Crystalline form of paroxetine.
PL377056A1 (pl) Nowe związki przeciwnowotworowe
GB2392617A (en) Surface Treatment of SARS-Infected Lungs

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed